SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen
IMGN 31.230.0%Feb 26 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gary Mohilner who wrote (5570)6/30/2016 3:11:55 PM
From: Gary Mohilner   of 5665
 
I wish I knew why, but as long as I can remember SGEN's been rumored as a buyout target, and I believe that's part of the reason it's traded for so much more than IMGN. Here's a current example:

siliconinvestor.com

At current prices, IMGN could be bought out for a tiny fraction of SGEN's current market cap. A billion dollar offer would be roughly four times our current price, and less than 20% of SGEN's market cap.

I've always believe IMGN's partners are its defense against such a buyout, but at current prices I frankly can't believe that no one is giving it a try. While a bidding war would be great for investors, if management fails to do something that dramatically increases share price, I've got to believe either a current partner, or perhaps even a competitor, will make an offer.

Gary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext